Meeder Asset Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Meeder Asset Management’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-40,000	Closed	-$4	–	628
2023 Q1	$4	Buy	+40,000	New	+$4	﹤0.01%	591
2021 Q4	–	Sell	-40,000	Closed	–	–	2593
2021 Q3	$0	Hold	40,000	–	–	﹤0.01%	2743
2021 Q2	$0	Hold	40,000	–	–	﹤0.01%	2772
2021 Q1	$0	Buy	+40,000	New	–	﹤0.01%	2533

Other funds holding RCPI

Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return

Meeder Asset Management's RCPI Position: Q2 2023 in Review

Meeder Asset Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2023, closing a stake of 40,000 shares — an estimated $4 sold.

Meeder Asset Management first reported a position in RCPI in Q1 2021 and held it in 4 quarters. The position peaked at $4 in Q1 2023. 1 fund tracked by Wall St. Rank holds RCPI as of Q2 2023.

Meeder Asset Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2023 after selling out during the quarter.
Meeder Asset Management sold 40,000 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2023, an estimated $4.
Meeder Asset Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q1 2021 and held it in 4 quarters.
Meeder Asset Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $4 in Q1 2023.
1 fund tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2023.

Based on Meeder Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.